{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:40:15Z","timestamp":1787946015093,"version":"build-2784847793"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"33","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970304"],"award-info":[{"award-number":["81970304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["18ZXZNSY00290"],"award-info":[{"award-number":["18ZXZNSY00290"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,31]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims\u2003<\/jats:title><jats:p>Emerging evidence has linked cholesterol metabolism with platelet responsiveness. We sought to examine the dose\u2013response relationship between low-density lipoprotein cholesterol (LDL-C) and major in-hospital bleeds in acute coronary syndrome (ACS) patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results\u2003<\/jats:title><jats:p>Among 42 378 ACS patients treated with percutaneous coronary intervention (PCI) enrolled in 240 hospitals in the Improving Care for Cardiovascular Disease in China-ACS project from 2014 to 2019, a total of 615 major bleeds, 218 ischaemic events, and 337 deaths were recorded. After controlling for baseline variables, a non-linear relationship was observed for major bleeds, with the higher risk at lower LDL-C levels. No dose\u2013response relationship was identified for ischaemic events and mortality. A threshold value of LDL-C &amp;lt;70\u2009mg\/dL was associated with an increased risk for major bleeds (adjusted odds ratio: 1.49; 95% confidence interval: 1.21\u20131.84) in multivariable-adjusted logistic regression models and in propensity score-matched cohorts. The results were consistent in multiple sensitivity analyses. Among ticagrelor-treated patients, the LDL-C threshold for increased bleeding risk was observed at &amp;lt;88\u2009mg\/dL, whereas for clopidogrel-treated patients, the threshold was &amp;lt;54\u2009mg\/dL. Across a full spectrum of LDL-C levels, the treatment effect size associated with ticagrelor vs. clopidogrel on major bleeds favoured clopidogrel at lower LDL-C levels, but no difference at higher LDL-C levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions\u2003<\/jats:title><jats:p>In a nationwide ACS registry, a non-linear association was identified between LDL-C levels and major in-hospital bleeds following PCI, with the higher risk at lower levels. As the potential for confounding may exist, further studies are warranted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: NCT02306616<\/jats:p><\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab418","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T11:09:42Z","timestamp":1624014582000},"page":"3175-3186","source":"Crossref","is-referenced-by-count":43,"title":["LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project"],"prefix":"10.1093","volume":"42","author":[{"given":"Qing","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital , 154 Anshan Road, Heping District , Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital , 154 Anshan Road, Heping District , Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6105-2774","authenticated-orcid":false,"given":"Chongzhe","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital , 154 Anshan Road, Heping District , Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Zeng","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Cardiology, Beijing Anzhen Hospital, Capital Medical University, the Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases , No.2 Anzhen Road, Chaoyang District , Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital , 154 Anshan Road, Heping District , Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital , 154 Anshan Road, Heping District , Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchen","family":"Hao","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Cardiology, Beijing Anzhen Hospital, Capital Medical University, the Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases , No.2 Anzhen Road, Chaoyang District , Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital , 154 Anshan Road, Heping District , Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongle","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital , 154 Anshan Road, Heping District , Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[{"name":"Heart Center, the First Hospital of Hebei Medical University , 89 Donggang Road, Shijiazhuang 050000, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9712-803X","authenticated-orcid":false,"given":"Yida","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking University Third Hospital , 49 Huayuanbei Road, Haidian District, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0480-0454","authenticated-orcid":false,"suffix":"Jr","given":"Sidney C","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of North Carolina at Chapel Hill , 6031 Burnett-Womack Building, Chapel Hill, NC 27599-7075, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Cardiology, General Hospital of Northern Theater Command , 83 Wenhua Road, Shenhe District, Shenyang 110801, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5407-8773","authenticated-orcid":false,"given":"Yong","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking University First Hospital , 8 Xishiku Street, Xicheng District, 100034 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University , 180 Fenglin Road, 200032 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5387-5957","authenticated-orcid":false,"given":"Changsheng","family":"Ma","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Cardiology, Beijing Anzhen Hospital, Capital Medical University, the Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases , No.2 Anzhen Road, Chaoyang District , Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3192-8093","authenticated-orcid":false,"given":"Gregg C","family":"Fonarow","sequence":"additional","affiliation":[{"name":"Division of Cardiology, David Geffen School of Medicine at University of California , Los Angeles, 100 UCLA Medical Plaza, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Morgan","sequence":"additional","affiliation":[{"name":"International Quality Improvement Department, American Heart Association , 7272 Greenville Ave, Dallas, TX 75231, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3311-0818","authenticated-orcid":false,"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Cardiology, Beijing Anzhen Hospital, Capital Medical University, the Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases , No.2 Anzhen Road, Chaoyang District , Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Cardiology, Beijing Anzhen Hospital, Capital Medical University, the Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases , No.2 Anzhen Road, Chaoyang District , Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengge","family":"Zhou","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Cardiology, Beijing Anzhen Hospital, Capital Medical University, the Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases , No.2 Anzhen Road, Chaoyang District , Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3239-3449","authenticated-orcid":false,"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Cardiology, Beijing Anzhen Hospital, Capital Medical University, the Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases , No.2 Anzhen Road, Chaoyang District , Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Cardiology, Beijing Anzhen Hospital, Capital Medical University, the Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases , No.2 Anzhen Road, Chaoyang District , Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-7103","authenticated-orcid":false,"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital , 154 Anshan Road, Heping District , Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CCC-ACS Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"2022102514472796500_ehab418-B1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/eurheartj\/ehz593","article-title":"Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry","volume":"41","author":"Simonsson","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102514472796500_ehab418-B2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"2022102514472796500_ehab418-B3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/ccd.28325","article-title":"A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study","volume":"93","author":"Chen","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"2022102514472796500_ehab418-B4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2169\/internalmedicine.1553-18","article-title":"The hypercholesterolemia paradox in percutaneous coronary intervention: an analysis of a multicenter PCI registry","volume":"58","author":"Ueshima","year":"2019","journal-title":"Intern Med"},{"key":"2022102514472796500_ehab418-B5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehq021","article-title":"Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis","volume":"31","author":"Ducrocq","year":"2010","journal-title":"Eur Heart J"},{"key":"2022102514472796500_ehab418-B6","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/CIRCULATIONAHA.110.002683","article-title":"Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel\u2014Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38","volume":"123","author":"Hochholzer","year":"2011","journal-title":"Circulation"},{"key":"2022102514472796500_ehab418-B7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/eurheartj\/ehn586","article-title":"Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention","volume":"30","author":"Iijima","year":"2009","journal-title":"Eur Heart J"},{"key":"2022102514472796500_ehab418-B8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","article-title":"PCSK9 (proprotein convertase subtilisin\/kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36","volume":"143","author":"Qi","year":"2021","journal-title":"Circulation"},{"key":"2022102514472796500_ehab418-B9","first-page":"e1046","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"2022102514472796500_ehab418-B10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102514472796500_ehab418-B11","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.jacc.2019.08.010","article-title":"Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)","volume":"74","author":"Koskinas","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102514472796500_ehab418-B12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.120.046320","article-title":"Effect of evolocumab on atherogenic lipoproteins during the peri- and early postinfarction period: a placebo-controlled, randomized trial","volume":"142","author":"Leucker","year":"2020","journal-title":"Circulation"},{"key":"2022102514472796500_ehab418-B13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCINTERVENTIONS.112.000159","article-title":"Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes","volume":"6","author":"Guptill","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102514472796500_ehab418-B14","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2017.08.018","article-title":"Characterization of the average daily ischemic and bleeding risk after primary PCI for STEMI","volume":"70","author":"Giustino","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102514472796500_ehab418-B15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ahj.2016.06.005","article-title":"Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: a national effort to prompt quality enhancement for acute coronary syndrome","volume":"179","author":"Hao","year":"2016","journal-title":"Am Heart J"},{"key":"2022102514472796500_ehab418-B16","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/eurheartj\/ehr422","article-title":"Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"32","author":"Becker","year":"2011","journal-title":"Eur Heart J"},{"key":"2022102514472796500_ehab418-B17","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/CIRCULATIONAHA.111.065904","article-title":"Serum lipids and lipoproteins in Chinese men and women","volume":"125","author":"Yang","year":"2012","journal-title":"Circulation"},{"key":"2022102514472796500_ehab418-B18","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1161\/CIRCULATIONAHA.108.795666","article-title":"Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study","volume":"119","author":"Noda","year":"2009","journal-title":"Circulation"},{"key":"2022102514472796500_ehab418-B19","doi-asserted-by":"crossref","first-page":"e012771","DOI":"10.1161\/JAHA.119.012771","article-title":"Low lipid levels and high variability are associated with the risk of new-onset atrial fibrillation","volume":"8","author":"Lee","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2022102514472796500_ehab418-B20","doi-asserted-by":"crossref","first-page":"m4266","DOI":"10.1136\/bmj.m4266","article-title":"Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study","volume":"371","author":"Johannesen","year":"2020","journal-title":"BMJ"},{"key":"2022102514472796500_ehab418-B21","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"2022102514472796500_ehab418-B22","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"2022102514472796500_ehab418-B23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacl.2017.09.007","article-title":"A randomized trial evaluating the efficacy and safety of alirocumab in South Korea and Taiwan (ODYSSEY KT)","volume":"12","author":"Koh","year":"2018","journal-title":"J Clin Lipidol"},{"key":"2022102514472796500_ehab418-B24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jacl.2019.10.015","article-title":"ODYSSEY EAST: alirocumab efficacy and safety vs ezetimibe in high cardiovascular risk patients with hypercholesterolemia and on maximally tolerated statin in China, India, and Thailand","volume":"14","author":"Han","year":"2020","journal-title":"J Clin Lipidol"},{"key":"2022102514472796500_ehab418-B25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12933-020-0991-1","article-title":"Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol","volume":"19","author":"Colhoun","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"2022102514472796500_ehab418-B26","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ahj.2015.03.004","article-title":"Efficacy and safety of the proprotein convertase subtilisin\/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: the ODYSSEY COMBO I study","volume":"169","author":"Kereiakes","year":"2015","journal-title":"Am Heart J"},{"key":"2022102514472796500_ehab418-B27","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1316222","article-title":"A 52-week placebo-controlled trial of evolocumab in hyperlipidemia","volume":"370","author":"Blom","year":"2014","journal-title":"N Engl J Med"},{"key":"2022102514472796500_ehab418-B28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41591-019-0366-x","article-title":"Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults","volume":"25","author":"Sun","year":"2019","journal-title":"Nat Med"},{"key":"2022102514472796500_ehab418-B29","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1212\/WNL.0000000000007853","article-title":"Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: a prospective study","volume":"93","author":"Ma","year":"2019","journal-title":"Neurology"},{"key":"2022102514472796500_ehab418-B30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jacl.2018.06.011","article-title":"Twenty-year epidemiologic study on LDL-C levels in relation to the risks of atherosclerotic event, hemorrhagic stroke, and cancer death among young and middle-aged population in China","volume":"12","author":"Zhang","year":"2018","journal-title":"J Clin Lipidol"},{"key":"2022102514472796500_ehab418-B31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"2022102514472796500_ehab418-B32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1910355","article-title":"A comparison of two LDL cholesterol targets after ischemic stroke","volume":"382","author":"Amarenco","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102514472796500_ehab418-B33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/CIRCRESAHA.113.302655","article-title":"Loss of plasma proprotein convertase subtilisin\/kexin 9 (PCSK9) after lipoprotein apheresis","volume":"113","author":"Tavori","year":"2013","journal-title":"Circ Res"},{"key":"2022102514472796500_ehab418-B34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.thromres.2004.04.001","article-title":"Shear stress-dependent platelet function after LDL cholesterol apheresis","volume":"113","author":"Spieker","year":"2004","journal-title":"Thromb Res"},{"key":"2022102514472796500_ehab418-B35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1538-7836.2003.00087.x","article-title":"Role of in vitro cholesterol depletion in mediating human platelet aggregation","volume":"1","author":"Grgurevich","year":"2003","journal-title":"J Thromb Haemost"},{"key":"2022102514472796500_ehab418-B36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1538-7836.2011.04217.x","article-title":"Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia","volume":"9","author":"Nagy","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2022102514472796500_ehab418-B37","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1161\/CIRCRESAHA.116.308955","article-title":"LNK\/SH2B3 loss of function promotes atherosclerosis and thrombosis","volume":"119","author":"Wang","year":"2016","journal-title":"Circ Res"},{"key":"2022102514472796500_ehab418-B38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.3150","article-title":"Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis","volume":"19","author":"Murphy","year":"2013","journal-title":"Nat Med"},{"key":"2022102514472796500_ehab418-B39","doi-asserted-by":"crossref","first-page":"16514","DOI":"10.1038\/s41598-020-73463-9","article-title":"Non-hematopoietic deficiency of proprotein convertase subtilisin\/kexin type 9 deficiency leads to more severe anemia in a murine model of sickle cell disease","volume":"10","author":"Venugopal","year":"2020","journal-title":"Sci Rep"},{"key":"2022102514472796500_ehab418-B40","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/CCM.0000000000000946","article-title":"Lipid paradox in acute myocardial infarction-the association with 30-day in-hospital mortality","volume":"43","author":"Cheng","year":"2015","journal-title":"Crit Care Med"},{"key":"2022102514472796500_ehab418-B41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.amjcard.2014.12.006","article-title":"Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox)","volume":"115","author":"Reddy","year":"2015","journal-title":"Am J Cardiol"},{"key":"2022102514472796500_ehab418-B42","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/jnci\/djr008","article-title":"Low-density lipoprotein cholesterol and the risk of cancer: a Mendelian randomization study","volume":"103","author":"Benn","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2022102514472796500_ehab418-B43","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/eurheartj\/ehy769","article-title":"Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States","volume":"40","author":"Potts","year":"2019","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/33\/3175\/46627104\/ehab418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/33\/3175\/46627104\/ehab418.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T02:41:34Z","timestamp":1699152094000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/33\/3175\/6340057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":43,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2021,7,29]]},"published-print":{"date-parts":[[2021,8,31]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab418","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,7,29]]}}}